5-(4-Trifluoromethoxyphenyl)-nicotinic acid
≥95%
- Product Code: 119757
CAS:
898796-62-8
| Molecular Weight: | 283.20 g./mol | Molecular Formula: | C₁₃H₈F₃NO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD06410279 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, dry and sealed |
Product Description:
This chemical is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various bioactive compounds, particularly those targeting inflammatory and neurological disorders. Its structural features, including the trifluoromethoxy group, enhance its ability to interact with specific biological targets, making it valuable in the development of novel therapeutic agents. Additionally, it is explored for its potential in creating molecules with improved pharmacokinetic properties, such as enhanced metabolic stability and bioavailability. Researchers also investigate its role in designing inhibitors for enzymes or receptors involved in disease pathways, contributing to advancements in drug discovery.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | £16.49 |
+
-
|
| 0.250 | 10-20 days | £32.57 |
+
-
|
5-(4-Trifluoromethoxyphenyl)-nicotinic acid
This chemical is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various bioactive compounds, particularly those targeting inflammatory and neurological disorders. Its structural features, including the trifluoromethoxy group, enhance its ability to interact with specific biological targets, making it valuable in the development of novel therapeutic agents. Additionally, it is explored for its potential in creating molecules with improved pharmacokinetic properties, such as enhanced metabolic stability and bioavailability. Researchers also investigate its role in designing inhibitors for enzymes or receptors involved in disease pathways, contributing to advancements in drug discovery.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :